First UK-based clinical trial manufacturer focused on viral vectors announces launch

ViroCell will supply viral vectors and gene modified cells, to academic and corporate clients, for translational cell and gene therapies going into clinical trials.

In the NewsFlorence BuchananCDMO, clinical trials, viral vectors, cell and gene therapies, CCR, Complete Clinical Research, gene therapy, cell therapy, vector design, AAV vectors, lentivirus vectors, UK CDMO, ViroCell, Edi Truell